Koninklijke Philips/€PHIA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Koninklijke Philips
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
- Ticker
- €PHIA
- Sector
- Health
- Primary listing
- AEX
- Employees
- 63,670
- Headquarters
- Amsterdam, Netherlands
- Website
- www.philips.com
PHIA Metrics
BasicAdvanced
€23B
20.45
€1.14
0.91
€0.85
3.64%
Price and volume
Market cap
€23B
Beta
0.91
52-week high
€27.89
52-week low
€20.93
Average daily volume
1.6M
Dividend rate
€0.85
Financial strength
Current ratio
1.257
Quick ratio
0.726
Long term debt to equity
0.55
Total debt to equity
0.65
Dividend payout ratio (TTM)
31.78%
Interest coverage (TTM)
6.08%
Profitability
EBITDA (TTM)
2,416
Gross margin (TTM)
45.94%
Net profit margin (TTM)
6.31%
Operating margin (TTM)
9.78%
Effective tax rate (TTM)
24.63%
Revenue per employee (TTM)
€280,000
Management effectiveness
Return on assets (TTM)
4.07%
Return on equity (TTM)
10.15%
Valuation
Price to earnings (TTM)
20.452
Price to revenue (TTM)
1.26
Price to book
2
Price to tangible book (TTM)
-28.75
Price to free cash flow (TTM)
13.797
Free cash flow yield (TTM)
7.25%
Free cash flow per share (TTM)
1.694
Dividend yield (TTM)
3.64%
Growth
Revenue change (TTM)
-1.06%
Earnings per share change (TTM)
555.00%
3-year revenue growth (CAGR)
-1.29%
10-year revenue growth (CAGR)
-1.66%
3-year earnings per share growth (CAGR)
-19.07%
10-year earnings per share growth (CAGR)
4.58%
10-year dividend per share growth (CAGR)
1.34%
What the Analysts think about PHIA
Analyst ratings (Buy, Hold, Sell) for Koninklijke Philips stock.
Analyst projections of the future price of Koninklijke Philips stock.
Bulls say / Bears say
Philips delivered 4% comparable sales growth in Q2, with growth across all segments, and kept its 2026 sales-growth outlook at 3%–4.5%. That points to continued demand across its healthcare and consumer businesses. (Philips)
The equipment order book remains at a record level, while order intake grew 5% over the 12 months to Q2. That provides a sizeable base of demand to convert into future sales. (Stock Analysis)
A Dutch court rejected shareholders’ request for an inquiry into Philips’ handling of the sleep-apnoea device recall, reducing one source of governance-related legal uncertainty. The ruling did not decide all claims linked to the recall. (Yahoo Finance)
The 16.4% Q2 adjusted EBITA margin included a 4.2-percentage-point US tariff refund; without it, the margin was 12.2% and underlying profitability slightly declined. This makes the headline improvement less durable than it appears. (Philips)
Comparable order intake fell 1% in Q2, and Philips described China as a structurally more challenging market amid new public-procurement rules. Weaker demand or delayed purchasing there could make growth targets harder to deliver. (MarketScreener)
A new recall of Philips Lumify ultrasound systems followed reports of four deaths and eight serious injuries, with a software issue potentially interrupting scans. The company was still working on a fix, adding a fresh product-safety and execution risk. (Radiology Business)
Data summarised monthly by Lightyear AI. Last updated on 17 Oct 2026.
PHIA Financial Performance
Revenues and expenses
PHIA Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing PHIA
AllEURUSDGBP
Fund name | Fund size | €PHIA weighting |
|---|---|---|
iShares AEX€IAEX | €781M | 1.78% |
iShares AEX£IAEX | €781M | 1.78% |
iShares MSCI Europe Health Care Sector€ESIH | €890M | 1.11% |
iShares MSCI Europe Health Care Sector£ESIH | €890M | 1.11% |
iShares STOXX Europe 600 Health Care€EXV4 | €709M | 1.07% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.